NCT02404376View on ClinicalTrials.gov

COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2019

Study Completion Date

June 30, 2020

Conditions
ST Elevation Acute Myocardial Infarction
Interventions
DRUG

Exenatide

Intravenous administration of Exenatide

OTHER

Remote Ischemic Conditioning (RIC)

Remote ischemic conditioning with a cuff in the arm

DRUG

Placebo

Intrevenous administration of Placebo

Trial Locations (6)

15706

Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela

25198

Hospital Universitario Arnau de Vilanova, Lleida

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

43005

Hospital Universitari de Tarragona Joan 23, Tarragona

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08035

Hospital Universitario Valle de Hebron, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT02404376 - COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial | Biotech Hunter | Biotech Hunter